Decentralized, Community-Based Treatment for Drug-Resistant Tuberculosis: Bangladesh Program Experience

BACKGROUND: Bangladesh is a highly populous country where the prevalence of drug-resistant tuberculosis (DR-TB) is growing. With the rapid increase in DR-TB notifications through GeneXpert technology, it was imperative to come up with a new treatment strategy that could keep up with the increase of...

Descripción completa

Detalles Bibliográficos
Autores principales: Daru, Paul, Matji, Refiloe, AlMossawi, Hala Jassim, Chakraborty, Krishnapada, Kak, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2018
Materias:
Field Action Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172109/
https://www.ncbi.nlm.nih.gov/pubmed/30287534
http://dx.doi.org/10.9745/GHSP-D-17-00345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172109/
https://www.ncbi.nlm.nih.gov/pubmed/30287534
http://dx.doi.org/10.9745/GHSP-D-17-00345

Ejemplares similares